Status:
COMPLETED
Initial Effect Size Estimation of a Smartwatch-based Intervention for Physical and Behavioral Activation in Depressed Patients
Lead Sponsor:
Max-Planck-Institute of Psychiatry
Conditions:
Depression
Eligibility:
All Genders
18-65 years
Brief Summary
It is well known that physical activity interventions have a robust, if small-to-moderate effect on the amelioration of chronic diseases, including major depressive disorder (MDD) (Singh et al. 2023)....
Eligibility Criteria
Inclusion
- Written consent for voluntary study participation
- Between 18 and 65 years of age
- Current diagnosis of a single episode of mild to moderate depressive disorder without psychotic symptoms, according to ICD-10 (F32.0, F32.1)
- Internet access and email address to answer electronic questionnaires
- Ability to read German
Exclusion
- Acute suicidality
- Pregnancy and breastfeeding
- Currently undergoing psychological treatment
- Current use of psychotropic medication
- Neurological or internal medical disease
- Diagnosis of a severe major depression or dysthymia according to ICD-10 (F32.2, F32.3, F33.2, F33.3, F34.1)
- Diagnosis of a psychotic disorder according to ICD-10 (F20-F29) in the life history
- Diagnosis of a bipolar disorder according to ICD-10 (F31) in life history
- Acute substance abuse (e.g., drug use or excessive alcohol and nicotine use)
- Diagnosis of dissociative disorder (F44) in life history
Key Trial Info
Start Date :
March 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 31 2024
Estimated Enrollment :
53 Patients enrolled
Trial Details
Trial ID
NCT06532097
Start Date
March 1 2023
End Date
January 31 2024
Last Update
November 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Max Planck Institute of Psychiatry
Munich, Bavaria, Germany, 80805